Impact of circulating biomarkers in patients with metastatic colorectal cancer treated with first-line FOLFOX-aflibercept therapy. Results of the GERCOR VELVET Phase II study. (December 2016)

Record Type:
Journal Article
Title:
Impact of circulating biomarkers in patients with metastatic colorectal cancer treated with first-line FOLFOX-aflibercept therapy. Results of the GERCOR VELVET Phase II study. (December 2016)
Main Title:
Impact of circulating biomarkers in patients with metastatic colorectal cancer treated with first-line FOLFOX-aflibercept therapy. Results of the GERCOR VELVET Phase II study
Authors:
Tijeras-Raballand, A.
De Gramont, A.
Chiron, M.
Bachet, J.B.
André, T.
Auby, D.
Desramé, J.
Baba-Ahmed, N.
Lecaille, C.
Lebrun, V.
Louvet, C.
Tournigand, C.
Benner, S.
Attia, M.
De Gramont, A.
Bonnetain, F.
Chibaudel, B.
Abstract:
Is Part Of:
European journal of cancer. Volume 69(2016)supplement 1
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Issue Display:
Volume 69, Issue 2016 (2016)
Year:
2016
Volume:
69
Issue:
2016
Issue Sort Value:
2016-0069-2016-0000
Page Start:
S147
Page End:
Publication Date:
2016-12
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0959-8049(16)33036-2 ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
2628.xml